M. Ling

发表

M. Ling, 1993, Journal of the American Academy of Dermatology.

A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis

A. Gottlieb, G. Scott, D. Pariser, 2005, The Journal of dermatological treatment.

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy.

R. Langley, J. Hanifin, M. Ling, 2001, Journal of the American Academy of Dermatology.

Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild‐to‐moderate toenail onychomycosis: results from three randomized studies using double‐blind vehicle‐controlled and open‐label active‐controlled designs

B. Elewski, M. Ghannoum, B. Damaj, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.

R. Moy, R. Matheson, N. Korman, 2005, Archives of dermatology.

Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.

E. Tschen, Lawrence Anderson, Janelle Katsamas, 2009, Journal of the American Academy of Dermatology.

Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.

D. Fivenson, G. Webster, E. Tanghetti, 2001, Cutis.

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.

M. Lebwohl, G. Weinstein, B. Goffe, 1997, Journal of the American Academy of Dermatology.

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.

J. Leyden, S. Kang, L. Drake, 1998, Journal of the American Academy of Dermatology.

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.

M. Lebwohl, J. Leyden, W. Eaglstein, 1998, Journal of the American Academy of Dermatology.

Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment.

Susan C. Taylor, T. Jones, A. Lucky, 2007, Journal of drugs in dermatology : JDD.

THERAPY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTIONS. PART II: METHODS OF TREATMENT

M. Ling, 1992, International journal of dermatology.

THERAPY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTIONS. PART I: INDICATIONS FOR AND JUSTIFICATION OF THERAPY

M. Ling, 1992, International journal of dermatology.

Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.

J. Jorizzo, R. Matheson, S. Dinehart, 2007, Journal of the American Academy of Dermatology.

Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.

A. Gottlieb, M. Lebwohl, Z. Draelos, 2004, Journal of the American Academy of Dermatology.

Dermatologic drug formulary: an American Academy of Dermatology white paper.

W. James, S. Resnick, M. Ling, 1996, Journal of the American Academy of Dermatology.

Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.

Sewon Kang, A. Menter, C. Langman, 2004, Journal of the American Academy of Dermatology.

Acitretin: optimal dosing strategies.

M. Ling, 1999, Journal of the American Academy of Dermatology.

Topical tacrolimus and pimecrolimus: future directions.

M. Ling, 2001, Seminars in cutaneous medicine and surgery.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.

J. Leyden, S. Kang, L. Drake, 1998, Journal of the American Academy of Dermatology.

Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.

B. Elewski, T. Phillips, M. Ling, 2006, Journal of drugs in dermatology : JDD.

Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections.

A. Fleischer, L. Eichenfield, M. Rico, 2002, Journal of the American Academy of Dermatology.

A randomized trial of etanercept as monotherapy for psoriasis.

A. Gottlieb, Sewon Kang, K. Gordon, 2003, Archives of dermatology.

Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.

E. Jeffes, J. Fowler, T. Phillips, 2004, Archives of dermatology.

Efficacy and Safety of Subantimicrobial Dose, Modified-Release Doxycycline 40 mg Versus Doxycycline 100 mg Versus Placebo for the treatment of Inflammatory Lesions in Moderate and Severe Acne: A Randomized, Double-Blinded, Controlled Study.

A. Bucko, A. Moore, M. Ling, 2015, Journal of drugs in dermatology : JDD.

A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.

J. Leyden, R. Gilbert, L. Kircik, 2013, Journal of drugs in dermatology : JDD.

Randomized, Double‐Blind, Placebo‐Controlled Study Evaluating the Lidocaine/Tetracaine Patch for Induction of Local Anesthesia prior to Minor Dermatologic Procedures in Geriatric Patients

N. Sadick, R. Pariser, D. Pariser, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Extemporaneous compounding. The end of the road?

M. Ling, 1998, Dermatologic clinics.

Subcutaneously Administered Efalizumab (Anti-CD 11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis

A. Gottlieb, B. Miller, P. Walicke, 2003 .

Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis

A. Gottlieb, B. Miller, P. Walicke, 2003, Journal of cutaneous medicine and surgery.

Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.

Z. Draelos, L. Kircik, E. Tanghetti, 2011, Journal of drugs in dermatology : JDD.

BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.

Z. Draelos, M. Gold, J. Fowler, 2018, The Journal of clinical and aesthetic dermatology.

Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.

A. Menter, J. Weiss, T. Jones, 2002, Cutis.

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis.

M. Lebwohl, K. Wittkowski, H. Ochs, 2000, Journal of the American Academy of Dermatology.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

B. Elewski, J. Leyden, Sewon Kang, 1998, Journal of the American Academy of Dermatology.